Original Research

Published on 12 Apr 2021

Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease

in Cytokines and Soluble Mediators in Immunity

Toshiyuki Kitoh
Tsuyoshi Ohara
Taichiro Muto
Akihisa Okumura
Reizo Baba
Yusuke Koizumi
Yuka Yamagishi
Hiroshige Mikamo
Kenji Daigo
Takao Hamakubo

Frontiers in Immunology

doi 10.3389/fimmu.2021.624802

4,286 views
15 citations

Original Research

Published on 01 Apr 2021

HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes

in Cytokines and Soluble Mediators in Immunity

Yifan Xiao
Yan Sun
Wei Liu
FanFan Zeng
Junyu Shi
Jun Li
Huoying Chen
Chang Tu
Yong Xu
Zheng Tan

Frontiers in Immunology

doi 10.3389/fimmu.2021.584097

4,892 views
11 citations

Review

Published on 30 Mar 2021

Role of the IL23/IL17 Pathway in Crohn’s Disease

in Cytokines and Soluble Mediators in Immunity

Heike Schmitt
Markus F. Neurath
Raja Atreya

Frontiers in Immunology

doi 10.3389/fimmu.2021.622934

38,413 views
109 citations

Systematic Review

Published on 29 Mar 2021

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions

in Cytokines and Soluble Mediators in Immunity

Michela Terri
Flavia Trionfetti
Claudia Montaldo
Marco Cordani
Marco Tripodi
Manuel Lopez-Cabrera
Raffaele Strippoli

Frontiers in Immunology

doi 10.3389/fimmu.2021.607204

16,895 views
65 citations

Review

Published on 26 Mar 2021

Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2

in Cytokines and Soluble Mediators in Immunity

Diana Garcia-del-Barco
Daniela Risco-Acevedo
Jorge Berlanga-Acosta
Frank Daniel Martos-Benítez
Gerardo Guillén-Nieto

Frontiers in Immunology

doi 10.3389/fimmu.2021.655528

8,689 views
21 citations

Original Research

Published on 26 Mar 2021

MicroRNA-497 Reduction and Increase of Its Family Member MicroRNA-424 Lead to Dysregulation of Multiple Inflammation Related Genes in Synovial Fibroblasts With Rheumatoid Arthritis

in Cytokines and Soluble Mediators in Immunity

Si Wang
Jing Xu
Yuanxu Guo
Yongsong Cai
Xiaoyu Ren
Wenhua Zhu
Manman Geng
Liesu Meng
Congshan Jiang
Shemin Lu

Frontiers in Immunology

doi 10.3389/fimmu.2021.619392

3,998 views
11 citations

Original Research

Published on 26 Mar 2021

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

in Cytokines and Soluble Mediators in Immunity

Francesca Caldarale
Mauro Giacomelli
Emirena Garrafa
Nicola Tamassia
Alessia Morreale
Piercarlo Poli
Silviana Timpano
Giulia Baresi
Fiammetta Zunica
Marco Cattalini

Frontiers in Immunology

doi 10.3389/fimmu.2021.654587

7,445 views
46 citations

Opinion

Published on 24 Mar 2021

Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins

in Cytokines and Soluble Mediators in Immunity

Masahiro Nishibori
Barbara S. Stonestreet

Frontiers in Immunology

doi 10.3389/fimmu.2021.656099

3,934 views
5 citations

Review

Published on 19 Mar 2021

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis

in Cytokines and Soluble Mediators in Immunity

Dennis McGonagle
Abdulla Watad
Kassem Sharif
Charlie Bridgewood

Frontiers in Immunology

doi 10.3389/fimmu.2021.614255

22,992 views
36 citations

Editorial

Published on 19 Mar 2021

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy

in Cytokines and Soluble Mediators in Immunity

Beatriz Martín-Antonio

Frontiers in Immunology

doi 10.3389/fimmu.2021.666703

3,439 views
2 citations

Original Research

Published on 19 Mar 2021

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

in Cytokines and Soluble Mediators in Immunity

Dan J. K. Yombo
Varshini Odayar
Nishant Gupta
Anil G. Jegga
Satish K. Madala

Frontiers in Immunology

doi 10.3389/fimmu.2021.645717

5,904 views
18 citations

Editorial

Published on 18 Mar 2021

Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis

in Cytokines and Soluble Mediators in Immunity

Fabrizio Antonangeli
Ola Grimsholm
Marianna Nicoletta Rossi
Francesca Velotti

Frontiers in Immunology

doi 10.3389/fimmu.2021.668876

3,265 views
5 citations

Review

Published on 16 Mar 2021

ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization

in Cytokines and Soluble Mediators in Immunity

Jan Damoiseaux

Frontiers in Immunology

doi 10.3389/fimmu.2021.656796

10,957 views
7 citations

Review

Published on 16 Mar 2021

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

in Cytokines and Soluble Mediators in Immunity

Praxedis Martin
Jérémie D. Goldstein
Loïc Mermoud
Alejandro Diaz-Barreiro
Gaby Palmer

Frontiers in Immunology

doi 10.3389/fimmu.2021.652846

13,848 views
55 citations

Review

Published on 15 Mar 2021

Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches

in Cytokines and Soluble Mediators in Immunity

Alice Pievani
Roberto Savoldelli
Juliane Poelchen
Elisa Mattioli
Giorgio Anselmi
Alice Girardot
Jochen Utikal
Pierre Bourdely
Marta Serafini
Pierre Guermonprez

Frontiers in Immunology

doi 10.3389/fimmu.2021.631279

6,646 views
7 citations

Original Research

Published on 11 Mar 2021

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8

in Cytokines and Soluble Mediators in Immunity

Mieke Metzemaekers
Sara Abouelasrar Salama
Jennifer Vandooren
Anneleen Mortier
Rik Janssens
Sofie Vandendriessche
Eva Ganseman
Erik Martens
Mieke Gouwy
Barbara Neerinckx

Frontiers in Immunology

doi 10.3389/fimmu.2021.644725

6,774 views
10 citations

Navigation group

Articles

Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease

HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes

Role of the IL23/IL17 Pathway in Crohn’s Disease

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions

Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2

MicroRNA-497 Reduction and Increase of Its Family Member MicroRNA-424 Lead to Dysregulation of Multiple Inflammation Related Genes in Synovial Fibroblasts With Rheumatoid Arthritis

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis

ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8